- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Achieving
the
End of AIDS
Achieving
the
End of
AIDS
The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:
- Deliver proven tools for immediate impacts.
- Demonstrate and roll out new HIV prevention tools.
- Develop long-term solutions to end the epidemic.
Spotlight
- February 2, 2023
We are only a month into the New Year and so much has happened in HIV prevention. Below are links to important resources on the latest developments. Opinion Piece: The Fight to Decriminalize Sex Work in South Africa: South Africa-based AVAC Fellow, Liyema Somnono published an opinion piece in Health-e News, Decriminalization of sex work can help prevent HIV, which unpacks the reasons for reforming South Africa’s outdated legislation that criminalizes “sex work” and legitimizing and recognizing sex work as work.
- January 27, 2023
South Africa could possibly reform its outdated and misguided criminal legislation that punishes consenting adults who offer or procure sexual services for money. AVAC supports the move toward decriminalization as evidence shows that its social, legal and economic injustices create a perfect storm for sex workers’ increased HIV risk.
- January 18, 2023
The Mosaico study, a large-scale HIV vaccine efficacy study also known as HVTN 706/HPX3002, was stopped early for non-efficacy. An independent data and safety monitoring board, at a scheduled review of the trial data, found the regimen to be safe, but that it did not meet the pre-defined criteria for efficacy and recommended that the study be stopped and trial participants informed.
- January 17, 2023
AVAC is excited to launch the Advocacy Navigator, an extension of our Advocacy Fellows program, which has involved more than 90 advocates and dozens of civil society organizations in 15 countries to drive groundbreaking advocacy on HIV prevention research, rollout, and human rights. AVAC now seeks applications from early-career professionals from Eastern and Southern Africa interested in strengthening their skills in HIV prevention advocacy.
What We Do
AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more
Px Methods
AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.